Skip to main content

Bausch Health downgraded to Neutral from Overweight at Piper Sandler

Piper Sandler analyst David Amsellem downgraded Bausch Health to Neutral from Overweight with a price target of $30, up from $25.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.